Medline, Inc. (MDLN)
39.17
-0.30
(-0.76%)
USD |
NASDAQ |
Nov 16, 16:00
38.43
-0.74
(-1.89%)
After-Hours: 04:59
Medline Gross Profit Margin (Quarterly) : 22.26% for Sept. 30, 2026
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 22.26% |
| June 30, 2026 | 26.52% |
| March 31, 2026 | 22.65% |
| December 31, 2025 | 22.32% |
| September 30, 2025 | 23.87% |
| June 30, 2025 | 25.11% |
| Date | Value |
|---|---|
| March 31, 2025 | 24.82% |
| December 31, 2024 | 24.68% |
| September 30, 2024 | 24.80% |
| June 30, 2024 | 24.16% |
| March 31, 2024 | 25.02% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| Abbott Laboratories | 50.36% |
| AngioDynamics, Inc. | 56.00% |
| Alphatec Holdings, Inc. | 62.30% |
| AtriCure, Inc. | 76.80% |
| Baxter International, Inc. | 33.30% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | 4.66% |
| Return on Assets | 2.27% |
| Return on Invested Capital | 2.72% |
| Profit Margin (Quarterly) | 4.09% |
| Operating Margin (Quarterly) | 7.76% |
| Return on Net Operating Assets | 2.55% |